Repeat-domain exposure defines seed-competent tau conformers

Mechanistic description

Tau assemblies become seed-competent when their repeat-domain surfaces adopt a conformation that both survives transfer and templates monomeric tau into pathological aggregates. This conformer-specific templating mechanism, supported by structural studies of disease-specific tau filaments, suggests that the exposed repeat domain interface is the critical determinant distinguishing pathogenic from non-pathogenic tau conformations. Non-pathogenic transferred tau lacks this exposed templating interface despite similar uptake, indicating that cellular internalization alone is insufficient for prion-like propagation. The probabilistic model of Alzheimer disease revised in 2022 suggests that such templated aggregation processes may be central to disease progression. Conformational exposure of the repeat domain thus defines seed-competent tau conformers and may represent a therapeutic target for preventing the establishment of the templating interface required for neurodegeneration.

Mechanism / pathway

MAPT
→
tau templated aggregation
→
neurodegeneration

Evidence for (8)

Propagation of Tau Aggregates and Neurodegeneration
Structural studies of disease-specific tau filaments
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.

PMID:34815562 2022 Nat Rev Neurosci
MAPT mutations, tauopathy, and mechanisms of neurodegeneration.

PMID:30742061 2019 Lab Invest
Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.

PMID:37095250 2023 Nat Med
Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.

PMID:27940599 2017 Cold Spring Harb Perspect Med
ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids.

PMID:34314701 2021 Cell
The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes.

PMID:38556838 2024 Alzheimers Dement

Evidence against (2)

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

PMID:31564456 2019 Cell

Evidence matrix

6 supporting 1 contradicting

53% posterior support

Supporting

The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. PMID:34815562 · 2022 · Nat Rev Neurosci
MAPT mutations, tauopathy, and mechanisms of neurodegeneration. PMID:30742061 · 2019 · Lab Invest
Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial. PMID:37095250 · 2023 · Nat Med
Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules. PMID:27940599 · 2017 · Cold Spring Harb Perspect Med
ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids. PMID:34314701 · 2021 · Cell
The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes. PMID:38556838 · 2024 · Alzheimers Dement

Contradicting

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. PMID:31564456 · 2019 · Cell

Bayesian persona consensus

53% posterior support

1 signal · 1 for / 0 against · agreement 100%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.

Cite this hypothesis

Citation

etl-backfill (2026). Repeat-domain exposure defines seed-competent tau conformers. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-3ab2bff6a46b

BibTeX

@misc{scidex_hypothesis_h3ab2bff,
  title        = {Repeat-domain exposure defines seed-competent tau conformers},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-3ab2bff6a46b},
  note         = {SciDEX artifact hypothesis:h-3ab2bff6a46b}
}